Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News PRISM BioLab and Talus Bioscience aim to crack the transcription factor code with dual-platform drug discovery strategy PRISM BioLab and Talus Bio have teamed up to crack transcription factor drug discovery. Find out how their dual-platform strategy could reshape precision medicine. byVenkateshDecember 18, 2025